Community based intervention to optimize osteoporosis management: randomized controlled trial.
BACKGROUND
Osteoporosis-related fractures are a significant public health concern. Interventions that increase detection and treatment of osteoporosis are underutilized. This pragmatic randomised study was done to evaluate the impact of a multifaceted community-based care program aimed at optimizing evidence-based management in patients at risk for osteoporosis and fractures.


METHODS
This was a 12-month randomized trial performed in Ontario, Canada. Eligible patients were community-dwelling, aged ≥55 years, and identified to be at risk for osteoporosis-related fractures. Two hundred and one patients were allocated to the intervention group or to usual care. Components of the intervention were directed towards primary care physicians and patients and included facilitated bone mineral density testing, patient education and patient-specific recommendations for osteoporosis treatment. The primary outcome was the implementation of appropriate osteoporosis management.


RESULTS
101 patients were allocated to intervention and 100 to control. Mean age of participants was 71.9 ± 7.2 years and 94% were women. Pharmacological treatment (alendronate, risedronate, or raloxifene) for osteoporosis was increased by 29% compared to usual care (56% [29/52] vs. 27% [16/60]; relative risk [RR] 2.09, 95% confidence interval [CI] 1.29 to 3.40). More individuals in the intervention group were taking calcium (54% [54/101] vs. 20% [20/100]; RR 2.67, 95% CI 1.74 to 4.12) and vitamin D (33% [33/101] vs. 20% [20/100]; RR 1.63, 95% CI 1.01 to 2.65).


CONCLUSIONS
A multi-faceted community-based intervention improved management of osteoporosis in high risk patients compared with usual care.


BACKGROUND
This trial has been registered with clinicaltrials.gov (ID: NCT00465387).
Ciaschini
Patricia M
PM
Algoma District Medical Group, Sault Ste. Marie, Canada.
Straus
Sharon E
SE
Dolovich
Lisa R
LR
Goeree
Ron A
RA
Leung
Karen M
KM
Woods
Carol R
CR
Zimmerman
Greg M
GM
Majumdar
Sumit R
SR
Spadafora
Silvana
S
Fera
Luke A
LA
Lee
Hui N
HN
D000368:Aged; D000369:Aged, 80 and over; D003153:Community Health Services / Q000379:methods* / Q000592:standards; D019468:Disease Management; D005260:Female; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*
CMAJ. 2009 Sep 1;181(5):265-71
19654194
Arch Intern Med. 2003 Oct 13;163(18):2165-72
14557214
J Gen Intern Med. 2007 Mar;22(3):362-7
17356969
Osteoporos Int. 2004 Oct;15(10):767-78
15258724
BMC Musculoskelet Disord. 2004 Apr 06;5:11
15068488
Lancet. 2002 May 18;359(9319):1761-7
12049882
Can J Public Health. 1992 Jul-Aug;83 Suppl 2:S7-11
1468055
CMAJ. 2000 Oct 3;163(7):819-22
11033708
Phys Ther. 2000 Sep;80(9):896-903
10960937
Arch Intern Med. 1991 Oct;151(10):2026-32
1929691
J Bone Miner Res. 1992 Sep;7(9):1005-10
1414493
Osteoporos Int. 2001;12(10):870-4
11716191
J Bone Miner Res. 2007 Nov;22(11):1808-15
17645403
J Am Geriatr Soc. 2008 Aug;56(8):1383-9
18808597
J Gen Intern Med. 2007 Mar;22(3):346-51
17356966
Arch Intern Med. 2007 Oct 22;167(19):2110-5
17954806
Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11
16448873
Osteoporos Int. 1997;7(5):407-13
9425497
J Bone Miner Res. 2000 Dec;15(12):2309-14
11127196
J Bone Miner Res. 1997 Mar;12(3):456-63
9076589
Trials. 2008 Nov 04;9:62
18983670
J Bone Joint Surg Am. 2003 Dec;85(12):2294-302
14668497
Phys Ther. 1997 Aug;77(8):812-9
9256869
CMAJ. 2002 Nov 12;167(10 Suppl):S1-34
12427685
Arch Intern Med. 1989 Nov;149(11):2445-8
2818106
Osteoporos Int. 2001;12(7):559-64
11527053
Semin Arthritis Rheum. 2006 Apr;35(5):293-305
16616152
BMJ. 2006 Dec 16;333(7581):1251-6
17170416
Ann Intern Med. 2004 Sep 7;141(5):366-73
15353428
Osteoporos Int. 2003 Sep;14(9):780-4
12904835
Osteoporos Int. 2001;12(4):271-8
11420776